Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æ¾ÏÀÇ Á¾¾çÇ¥½ÄÀڷμ­ CA 15-3¿Í CEAÀÇ ºñ±³ Comparison of CA 15-3 with CEA as Tumor Marker of Breast Cancer

´ëÇѾÏÇÐȸÁö 1992³â 24±Ç 6È£ p.829 ~ 833
¼±µ¿ÀÏ, Á¶±â¿ø, ±è¿ë¼®, ±èÁ¾´ö,
¼Ò¼Ó »ó¼¼Á¤º¸
¼±µ¿ÀÏ (  ) 
°¡Å縯´ëÇб³

Á¶±â¿ø (  ) 
°¡Å縯´ëÇб³
±è¿ë¼® (  ) 
°¡Å縯´ëÇб³
±èÁ¾´ö (  ) 
°¡Å縯´ëÇб³

Abstract


There has been strong need for a simple, specific and sensitive tumor marker in diagnosing and following up the patients with breast cancer. Many markers have been developed and investigated, but CEA and CA 15-3 are two of the most widely used
tumor
markers for this disease.
In this study, we compared the CA 15-3 with CEA, Clinical analysis was performed on 67 patients diagnosed with breast cancer who were admitted to KangNam St. Mary's Hospital, Seoul, Korea, from Feb. 1985 to Apr. 1990.
@ES The results were as follows:
@EN 1) For groups with no evidence of metastatic breast cancer, there was no difference between the average value of CEA and CA 15-3 detected
2) All(100%) of the metastatic cases showed the significantly elevated level of CA 15-3, compared to 56% that showed CEA elevation
Our results indicate that CEA and CA 15-3 are not suitable for screening and diagnosis of patients with breast cancer, since they are not elevated in nonmetatatic primary breast cancer patient. Howerer, CA 15-3 is superior to CEA in detecting
recurrent
or metastatic breast cancer.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS